Nicola Ryan (@nicolaryani1) 's Twitter Profile
Nicola Ryan

@nicolaryani1

Interventional Cardiologist. European 🇮🇪 in the UK. Swammer. Runner.

ID: 1130464577521627142

calendar_today20-05-2019 13:25:33

613 Tweet

630 Followers

66 Following

EuroIntervention (@eurointerventio) 's Twitter Profile Photo

The PCR London Valves edition is out!🔉Current debates in valvular disease; long-term risk of unplanned PCI after TAVI; incidence of aortic regurgitation using the ACURATE neo2; Dual ProGlide vs ProGlide and FemoSeal; and more…ow.ly/rlem50LHPQz

The PCR London Valves edition is out!🔉Current debates in valvular disease; long-term risk of unplanned PCI after TAVI; incidence of aortic regurgitation using the
ACURATE neo2; Dual ProGlide vs ProGlide and FemoSeal; and more…ow.ly/rlem50LHPQz
Nicola Ryan (@nicolaryani1) 's Twitter Profile Photo

#QFR guided strategy continues to provide better out comes at 2 years in FAVOR III China Do you use QFR in daily practice? How will it fit into future guidelines?

#QFR guided strategy continues to provide better out comes at 2 years in FAVOR III China 

Do you use QFR in daily practice? 

How will it fit into future guidelines?
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

#PCRLV simultaneous publication: in the multicentre ACURATE neo2 PMCF study, patients treated with the ACURATE neo2 had a low pacemaker implantation rate, early improvements in valve haemodynamics, and a low rate of moderate or greater paravalvular leak. eurointervention.pcronline.com/article/clinic…

#PCRLV simultaneous publication: in the multicentre ACURATE neo2 PMCF study, patients treated with the ACURATE neo2 had a low pacemaker implantation rate, early improvements in valve haemodynamics, and a low rate of moderate or greater paravalvular leak. eurointervention.pcronline.com/article/clinic…
PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

❓How satisfied are you with 📕EuroIntervention? 👨‍💻 Share your feedback in a 3-minute survey! 🎁The first 100 respondents get free 1-year access to the PCR-EAPCI Textbook: fr.surveymonkey.com/r/MP8KNWR #EuroPCR #interventionalcardiology

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Coinciding with their presentation at #EuroPCR. this year we will publish data on: 1) T-provisional vs culotte at 5 y (EBC-TWO) 2) VA-ECMO vs usual care (EURO-SHOCK) 3) A novel Mg scaffold (BIOMAG-1) 4) TAVI for bicuspid AS (BIVOLUT-X) 5) A first-in-class biomimetic THV (DurAVR)

Coinciding with their presentation at #EuroPCR. this year we will publish data on:
1) T-provisional vs culotte at 5 y (EBC-TWO)
2) VA-ECMO vs usual care (EURO-SHOCK)
3) A novel Mg scaffold (BIOMAG-1)
4) TAVI for bicuspid AS (BIVOLUT-X)
5) A first-in-class biomimetic THV (DurAVR)
PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

Hey #CardioTwitter, it's PCR Innovators Day: focus 🔦 on the latest devices, features & projects in interventional cardiovascular medicine Course Directors Azeem Latib Nicolo Piazza & José Calle Gordo await you from 09h in Théatre Havane! #PCRID #EuroPCR

Hey #CardioTwitter, it's PCR Innovators Day:  
focus 🔦 on the latest devices, features & projects in interventional cardiovascular medicine

Course Directors <a href="/azeemlatib/">Azeem Latib</a> <a href="/nicolo_piazza/">Nicolo Piazza</a> &amp; José Calle Gordo await you from 09h in Théatre Havane! 

#PCRID #EuroPCR
PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

🔥 #ACC25 Late-Breaking Trials 🔥: WARRIOR Nicola Ryan provides her take on the primary and secondary outcomes 📊 of the Women's Ischemia Trial which studied the reducation of events in non-obstructive coronary artery disease. 🔗pcronline.com/News/Whats-new…

🔥 #ACC25 Late-Breaking Trials 🔥: WARRIOR 

<a href="/NicolaRyanI1/">Nicola Ryan</a>  provides her take on the primary and secondary outcomes 📊 of the Women's Ischemia Trial which studied  the reducation of events in  non-obstructive coronary artery disease.

🔗pcronline.com/News/Whats-new…